Clinical Guideline on the Use of Intravenous Gammaglobulin in Children with Kawasaki Disease: Prevention of Coronary Artery Lesions

This Guideline had been developed by the Quality Assurance Sub-committee, COC in Paediatrics and the expert authors for the Hospital Authority according to the state of medical knowledge at the time of publication. It has been established that doctors can act in accordance with a practice accepted as proper by a responsible body of medical opinion even though others may adopt a different practice. As such, this guideline is for general guidance only; the management of individual cases must be the clinical judgment and decision of the medical practitioners after considering all relevant circumstances, information Guideline Development Panel Dr. TC Yung (Chairman) Dr. LY So Dr. HK Ho Dr. E Cheung